Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cerapedics Inc.

www.cerapedics.com

Latest From Cerapedics Inc.

People Briefs

Stryker CFO retires and Osiris Therapeutics CEO resigns, as SpineGuard and Tandem Diabetes Care expand management teams.

Medical Device Business Strategies

High Court Won’t Hear InFuse Off-Label Preemption Case

The case would have tested whether manufacturers could be held liable if an FDA-approved device injured a patient when the product was employed for an off-label, unapproved use. The Oklahoma Federal Court and the 10th Circuit Court of Appeals had both previously ruled in industry’s favor.

Medical Device Legal Issues

Spine Market: Pure Plays Continue to Grab Share

Amidst low growth and a potential rebound in the $9 billion global spine market, the pure-play spine companies, including NuVasive, Globus, K2M and LDR, continue to outperform and grab share from the diversified giants. Medtech Insight founder and former CEO Sharon O'Reilly reports on these companies and more from the 2015 North American Spine Society (NASS) conference in Chicago, where the latest news centered around ancillary approaches to fusion, patient-specific tools, robotics, biologics, expandable cages, MIS and cervical discs.

Medical Device Deals

Cervical Spine Bone Graft Gains FDA Go-Ahead

Cerapedics' i-Factor peptide-enhanced bone graft will be used to treat degenerative cervical disc disease, the first bone graft product PMA-approved for that indication, the company says.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • CeraPedics LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cerapedics Inc.
  • Senior Management
  • Glen A Kashuba, CEO
    Drew Trivisonno, CFO
    Jerome Connor, PhD, VP, R&D
    Jeffrey G Marx, PhD, Pres. & COO
    Andrew W Barnes, VP, US Sales
    Tommy Vollmar, VP, Mktg.
    Patrick O'Connor , VP, Clinical & Mkt. Dev.
  • Contact Info
  • Cerapedics Inc.
    Phone: (303) 974-6275
    11025 Dover St., Ste. 1600
    Westminster, CO 80021
    USA
UsernamePublicRestriction

Register